Literature DB >> 15967014

Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma.

Katrin Hirsch1, Ralf J Ludwig, Manfred Wolter, Thomas M Zollner, Katja Hardt, Roland Kaufmann, Wolf-Henning Boehncke.   

Abstract

Eosinophilic cellulitis (Wells' syndrome) is an inflammatory dermatosis characterized by marked eosinophilic infiltrates. Drugs and various infections are recognized causes of eosinophilic cellulitis. Eosinophilic cellulitis has been reported in non-hematological malignancies in two patients with squamous cell carcinoma and one with nasopharyngeal carcinoma. We report the association of eosinophilic cellulitis with adenocarcinoma of the colon. Curative hemicolectomy led to a complete remission, suggesting that underlying malignancies can trigger eosinophilic cellulitis.

Entities:  

Mesh:

Year:  2005        PMID: 15967014     DOI: 10.1111/j.1610-0387.2005.05726.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  5 in total

Review 1.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

2.  Wells' syndrome associated with ulcerative colitis: a case report and literature review.

Authors:  Sonali S Sakaria; Anupama Ravi; Robert Swerlick; Shanthi Sitaraman
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

3.  Wells Syndrome with Multiorgan Involvement Mimicking Hypereosinophilic Syndrome.

Authors:  M Carlesimo; L Fidanza; E Mari; G Feliziani; A Narcisi; G De Marco; A Bartolazzi; G Camplone
Journal:  Case Rep Dermatol       Date:  2009-09-12

4.  Wells Syndrome as a Rare Cause of Unilateral Ptosis.

Authors:  Caroline Janssen; Noémie Lauwers; Inge Leysen
Journal:  Ocul Oncol Pathol       Date:  2021-01-28

5.  Systemic lupus erythematosus associated with Wells' syndrome.

Authors:  Geng Yin; Qibing Xie
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 3.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.